We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FGP
1826
DELISTED
Ferrellgas Partners, L.P.
FGP
– –
-13,800
Closed -$308K
CARB
1827
DELISTED
Carbonite Inc
CARB
– –
-15,700
Closed -$236K
HOS
1828
DELISTED
Hornbeck Offshore Services, Inc.
HOS
– –
-10,952
Closed -$629K
CBM
1829
DELISTED
Cambrex Corporation
CBM
– –
-10,394
Closed -$137K
BKS
1830
DELISTED
Barnes & Noble
BKS
– –
-28,138
Closed -$239K
ARRY
1831
DELISTED
Array Biopharma Inc
ARRY
– –
-34,486
Closed -$215K
ANDX
1832
DELISTED
Andeavor Logistics LP
ANDX
– –
-9,634
Closed -$559K
SDLP
1833
DELISTED
SEADRILL PARTNERS LLC
SDLP
– –
-890
Closed -$291K
CBK
1834
DELISTED
Christopher & Banks Corporation
CBK
– –
-14,885
Closed -$107K
ELLI
1835
DELISTED
Ellie Mae Inc
ELLI
– –
-11,804
Closed -$378K
RDC
1836
DELISTED
Rowan Companies Plc
RDC
– –
-15,807
Closed -$580K
TFCFA
1837
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
– –
-10,334
Closed -$346K
ICON
1838
DELISTED
Iconix Brand Group, Inc.
ICON
– –
-1,612
Closed -$536K
AHL
1839
DELISTED
ASPEN Insurance Holding Limited
AHL
– –
-10,882
Closed -$395K
DNB
1840
DELISTED
Dun & Bradstreet
DNB
– –
-3,636
Closed -$378K
VVC
1841
DELISTED
Vectren Corporation
VVC
– –
-11,968
Closed -$399K
ESIO
1842
DELISTED
Electro Scientific Industries
ESIO
– –
-23,388
Closed -$274K
TSRO
1843
DELISTED
TESARO, Inc.
TSRO
– –
-6,995
Closed -$271K
ECYT
1844
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-16,235
Closed -$216K
LKM
1845
DELISTED
Link Motion Inc.
LKM
– –
-12,500
Closed -$272K
KERX
1846
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-43,916
Closed -$444K
ARII
1847
DELISTED
American Railcar Industries, Inc.
ARII
– –
-5,727
Closed -$225K
AET
1848
DELISTED
Aetna Inc
AET
– –
-27,128
Closed -$1.74M
KMG
1849
DELISTED
KMG Chemicals Inc
KMG
– –
-14,446
Closed -$318K
CALL
1850
DELISTED
magicJack VocalTec Ltd
CALL
– –
-11,824
Closed -$152K
72 73
74
75 76

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.